HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Influence of apolipoprotein E genotype on cerebral amyloid angiopathy in the elderly.

AbstractBACKGROUND AND PURPOSE:
The inheritance of the epsilon 4 allele of the apolipoprotein E gene (APOE) is associated with increased risk of developing dementia of the Alzheimer type (DAT). We have investigated whether the APOE genotype influences the severity of cerebral amyloid angiopathy (CAA) in elderly individuals with or without DAT.
METHODS:
From a consecutive autopsy series, we studied 88 patients (85.2 +/- 8.1 years) without degenerative disorders other than DAT. The percentages of amyloid-laden vessels in the occipital lobes were calculated and compared between APOE genotypes.
RESULTS:
For epsilon 3/3 and epsilon 3/4 genotypes, there was a trend toward increased CAA in epsilon 3/4 individuals for non-DAT and conversely in epsilon 3/3 individuals for DAT patients, but these did not achieve significance.
CONCLUSIONS:
The present study suggests that the epsilon 4 allele is not a strong risk factor for CAA in elderly people.
AuthorsY Itoh, M Yamada, N Suematsu, M Matsushita, E Otomo
JournalStroke (Stroke) Vol. 27 Issue 2 Pg. 216-8 (Feb 1996) ISSN: 0039-2499 [Print] United States
PMID8571412 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Apolipoprotein E4
  • Apolipoproteins E
  • DNA
Topics
  • Aged
  • Aged, 80 and over
  • Alleles
  • Alzheimer Disease (epidemiology, genetics, mortality)
  • Apolipoprotein E4
  • Apolipoproteins E (genetics)
  • Brain (metabolism)
  • Cerebral Amyloid Angiopathy (epidemiology, genetics, mortality)
  • DNA (analysis)
  • Genotype
  • Humans
  • Middle Aged
  • Risk Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: